Introduction {#sec1_1}
============

Mesenchymal hamartoma of the liver (MHL) is a benign lesion that classically presents as an enlarging abdominal mass in children before the age of two. Maresch initially described the tumor in 1903, but the term MHL was first used by Edmondson in 1956 \[[@B1]\]. MHL may affect either lobe of the liver and presents as a cystic or solid mass, and on occasion both components may be present. Alkaline phosphatase, β-human chorionic gonadotropin, serum transaminases and a-fetoprotein are usually within normal limits in patients with MHL. Hematoxylin and eosin staining as well as immunohistochemical studies \[[@B2],[@B3]\] have described MHL as having spindle cells positive for vimentin and smooth muscle actin and negative for CD31, CD34 and S100 proteins, while the ducts stain positive for cytokeratin 7 and negative for cytokeratin 20. Even though the exact pathogenesis of MHL is largely unknown, the most common theory is that it represents aberrant primitive mesenchyme development in the portal tract likely relating to the bile ducts.

Case Report {#sec1_2}
===========

A 53-year-old white female presented in January 2007 with colicky abdominal pain secondary to ureteral stones; subsequent abdominal ultrasound imaging and a CT scan of the abdomen demonstrated an incidental liver mass ([fig. 1](#F1){ref-type="fig"}). This lesion was initially thought to be a hemangioma, however follow-up imaging demonstrated an increase in the size of the mass, notably the solid component. This change in size as well as the characteristics of the mass prompted percutaneous biopsy in May 2008, which was nondiagnostic. The patient was referred for a hepatobiliary surgical consult. The patient\'s past surgical history was noncontributory, consisting of cyst removal of the left breast at the age of 16, a partial thyroidectomy in 2001 and a total abdominal hysterectomy with partial oophorectomy in 2006.

The preoperative work-up included a CEA level of \<0.5 ng/ml, an a-fetoprotein level of 3.6 ng/ml, a CA 19-9 level of 17 U/ml, a negative hepatitis panel, a total bilirubin level of 0.3 mg/dl, an alkaline phosphatase level of 87 U/l, an aspartate transaminase level of 45 U/l and an alanine transaminase level of 50 U/l. Repeat abdominal CT scan ([fig. 2](#F2){ref-type="fig"}) revealed an enlarging heterogeneous, progressively enhancing solid and cystic mass in the anterior segment of the right hepatic lobe (Couinaud\'s segments V and VIII). The mass measured 8.9 × 8.7 × 7.5 cm and displaced hepatic and portal veins. As a result of the increasing size of this partially cystic and solid liver mass over the course of 18 months, surgical excision of the mass was recommended.

In July 2008, the patient underwent a right trisegmentectomy and cholecystectomy. The pathological report identified a 19 × 17 × 11 cm resected hepatic lobe weighing 1,006 g, with a 9 × 9 × 7.5 cm, well-circumscribed, pink-yellow-tan, gelatinous mass, with a 1 cm clear surgical margin. The mass was cystic in the central portion and contained 30 ml of clear, yellowish fluid. Histologically, the mass consisted of rare benign dilated bile ducts ([fig. 3](#F3){ref-type="fig"}) corresponding to the cystic areas noted grossly, as well as myxoid stroma with spindle cells showing smooth muscle differentiation confirmed by positive staining for vimentin, smooth muscle actin and desmin. The mass\' fibrous capsule showed bile duct proliferation at the edge with a sharp transition to normal liver parenchyma. CD34 and hormone receptor studies were negative, thus excluding solitary fibrous tumor and angiomyxoma. The patient\'s hospital course was uneventful and she was discharged home on postoperative day five.

Discussion {#sec1_3}
==========

MHL is a benign lesion of the liver representing the second most common pediatric liver tumor (after hepatoblastoma) and constitutes 8% of all pediatric tumors. Eighty percent of the lesions are found by the age of two and the remainder are identified by five years of age with the male to female ratio being 2:1 \[[@B2]\]. Intrauterine MHL cases have been documented in several reports. Laberge et al. \[[@B4]\] reviewed twelve cases with eight fetuses surviving to term after being diagnosed ultrasonographically in the third trimester. Tumor resection in these eight cases occurred in the first three months of life. In the four lethal intrauterine MHL cases, Laberge et al. attributed the fetal demise to mass effects of the tumor causing compression of the heart, kidneys and umbilical veins \[[@B4]\]. Although the majority of MHL cases reported are in the pediatric population, 30 cases have been reported in the English and Japanese language literature in adults ranging in age from 19 to 69 years ([table 1](#T1){ref-type="table"}) \[[@B5],[@B6],[@B7]\]. Of these 30 cases, 22 (73%) have been reported in females and only 8 (27%) in males, with an average age of 40 and 57, respectively. Thus, males are more often affected in the pediatric population while females are more often affected in the adult population.

The clinical presentation of MHL appears to depend on the age of the patient. Most pediatric patients present with painless abdominal enlargement normally appreciated by the parent. If the mass becomes significantly large or liver function becomes compromised, ascites and jaundice may ensue. In severe cases there may be compression of the diaphragm and lungs causing respiratory difficulties. Although the adult case presented here was asymptomatic, Cook et al. \[[@B2]\] reported on eight adult cases, seven of whom were symptomatic, with the presenting complaint being diffuse abdominal pain. In agreement with Cook et al., a retrospective analysis of 17 cases by Yesim et al. \[[@B8]\] report that 10 cases were symptomatic. In addition to diffuse abdominal pain, reported symptoms and signs include hepatomegaly, right hypochondriac pain and left upper quadrant pain.

Radiographic appearance of MHL represents a continuum from predominantly cystic to mostly solid tumors. In pediatric patients the literature is unclear in regards to the cystic or solid nature of MHL. Early studies by Stocker and Ishak \[[@B9]\] describe nearly all pediatric cases as having cysts, however Chau et al. \[[@B10]\] reported that children more commonly have solid lesions. Interestingly, Chau et al. have also reported that adults have predominantly cystic lesions \[[@B10]\] while Hernandez et al. \[[@B5]\] have published that both pediatric and adult cases are primarily cystic. In the adult population, when solely cystic or solid tumors are present, females were more likely to have a cystic tumor, while males showed no predilection. When both cystic and solid portions of MHL were encountered, females were predominantly affected.

Location of the tumor in the liver appears to be different between pediatric and adult patients. MHL in children is primarily localized to the right lobe \[[@B10]\], while in adults, 12 cases (40%) were localized to the left lobe, 12 (40%) to the right lobe and in 6 (20%) tumors crossed into both lobes. Interestingly, adult males have a predilection for the right lobe of the liver, while females primarily have MHL in the left lobe. In situations when MHL was found in both lobes, females were more commonly affected than males.

Ultrasonography is typically the initial evaluation technique for suspected hepatic masses since it is readily accessible, can quickly delineate the cystic or solid nature of the lesion, and provides an estimate of mass size. CT imaging and/or MRI typically follow ultrasonography, particularly in preparation for surgical resection of the tumor. Ultrasonographic images of MHL show anechoic cystic regions with intervening thin septations, and axial imaging is helpful to further demonstrate the cystic or solid nature of MHL \[[@B11]\]. On contrast-enhanced CT the solid component of MHL will enhance while the cystic portion will not \[[@B11]\]. MRI shows a characteristic low signal intensity on T1-weighted images and high intensity imaging on T2-weighted imaging \[[@B12]\] ([table 2](#T2){ref-type="table"}).

Even though multiple radiographic imaging techniques may be employed in the evaluation of a hepatic mass, imaging results for MHL are nonspecific. The differential diagnosis for predominantly cystic lesions includes: simple hepatic cyst, hydatid cyst, subcapsular pseudocyst, biliary cystadenocarcinoma, and cystic metastasis. Mortele and Ros \[[@B13]\] depict the radiographic nature of a variety of cystic liver lesions, particularly noting CT and MRI subtleties that may be helpful in diagnosis. In the case of a solid lesion, focal nodular hyperplasia, hepatic adenoma, cavernous hemangioma, angiomyolipoma, solitary hamartoma, and hepatocellular carcinoma are among the more common lesions to consider. A solid MHL may present as a hypovascularized lesion on angiography \[[@B13]\], but this is a nonspecific finding and not helpful in differentiating from the aforementioned lesions. In the present case fine needle biopsy did not reveal a definitive diagnosis, necessitating surgical excision of the lesion.

Recent cytogenetic studies have shown MHL to involve rearrangements at chromosome 19. Analysis of eight MHL cases revealed the following genetic abnormalities: three involving t(11;19)(q13;q13.4), and single cases of t(11;19)(q13;q13.3), t(15;19)(q15;q13.4), a rearrangement of 11q2, 17q11 and 19q13.3, del(19)(q13.1q13.4) and t(11;19)(q11;q13.4) \[[@B14]\]. A significant finding is the similar genetic profile MHL shares with undifferentiated embryonal sarcoma (UES). UES is a rare pediatric malignancy composed of a sarcomatous mesenchymal component, as well as having hypercellular stroma, nuclear pleomorphism and mitotic activity, interspersed with benign branching ductal structures \[[@B3]\]. Over the past few years a number of cases of UES have developed within MHL, displaying similar genetic rearrangements in the region of 19q13.4 \[[@B3], [@B15], [@B16]\]. These include two cases of (19)(q13.4) and one case showing t(11;19) (q11;q13.3-13.4), nearly identical to genetic rearrangements seen in previous solitary cases of MHL \[[@B16]\]. Rajaram et al. \[[@B14]\] have postulated that the t(11;19) translocation is likely related to the development of solitary cases of MHL, but for progression of MHL to UES additional genetic alterations at other loci are required.

In addition to cytogenetic similarities, histological resemblance provides a potential link for progression from a benign MHL lesion to malignant UES. In cases described by Lauwers et al. \[[@B3]\] and Begueret et al. \[[@B15]\], UES regions were separated from MHL areas by transitional zones containing a histological mixture of the two entities. On further analysis, similar immunohistochemical characteristics and DNA ploidy of the three zones led Begueret et al. to conclude a coexistence of a well-differentiated phenotype (MHL) and a sarcomatous region (UES), separated by a zone containing a mixture of the two entities \[[@B15]\].

Hepatic angiosarcoma is the most common primary sarcoma of the liver and a solo case was recently reported to arise from an adult MHL \[[@B6]\]. Although hepatic angiosarcoma is usually associated with thorotrast, vinyl chloride and arsenic exposure, Li et al. \[[@B6]\] report a case of a woman with no prior carcinogen exposure presenting with an angiosarcoma arising from an untreated, previously diagnosed MHL. Though not direct evidence of MHL malignant transformation to angiosarcoma, the premalignant potential of MHL should be expanded to include UES and angiosarcoma, particularly when MHL is encountered in adult patients.

Although less invasive laparoscopic techniques are desirable, anatomic or nonanatomic resection with a negative margin is the standard treatment. The potential for massive tumor growth and possible degeneration to UES and/or angiosarcoma provides additional support against cautious clinical monitoring if the patient is a reasonable surgical candidate. Enlarging solid or cystic neoplasms of the liver that cannot be accurately diagnosed with radiographic imaging and histology should be considered for en bloc surgical resection with negative surgical margins.

Conclusion {#sec1_4}
==========

MHL in adults is a rare and potentially premalignant lesion that presents as a solid/cystic neoplasm. Symptoms are typically nonspecific, though abdominal pain is the most common. Laboratory results are noncontributory and radiographic imaging is variable and inconclusive. Needle biopsy is rarely diagnostic and surgical excision of symptomatic or enlarging lesions is recommended to exclude the possibility of malignancy and to establish a further diagnosis. The emerging literature suggests a relationship between MHL and UES in regards to histological similarities and cytogenetic analysis, and supports a recommendation for aggressive surgical management when feasible.
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![Noncontrast CT scan from February 2007 demonstrating a 5.3 cm septate hypodense cystic lesion in the right lobe of the liver.](crg0004-0084-f01){#F1}

![Repeat abdominal CT scan in July 2008 revealing an enlarging heterogeneous, progressively enhancing solid and cystic mass in the anterior segment of the right hepatic lobe (Couinaud\'s segments V and VIII). The mass measures 8.9 × 8.7 × 7.5 cm and displaces hepatic and portal veins.](crg0004-0084-f02){#F2}

![Microscopic image. The liver mass consists of rare benign dilated bile ducts corresponding to the cystic areas. The cytologically benign stroma is extremely myxoid with spindle cells. The mass had a fibrous capsule with bile duct proliferation at the edge with a sharp transition into the normal liver tissue (arrow), diagnostic of mesenchymal hamartoma. 10×, HE stain.](crg0004-0084-f03){#F3}

###### 

Cases of adult MHL

  Number   Reference                  Age   Gender   Liver lobe      Size             Gross appearance
  -------- -------------------------- ----- -------- --------------- ---------------- ------------------
  1        Yamamura \[[@B17]\]        22    F        both            not described    cystic
  2        Grases \[[@B18]\]          19    F        left            24×19×8 cm       cystic
  3        Dooley\[[@B19]\]           21    F        right           26×20×13 cm      cystic
  4        Kurokawa \[[@B20]\]        43    F        left            22×15×10 cm      solid
  5        Ishizuka \[[@B21]\]        59    M        not described   30×28×12 cm      cystic
  6        Kawakami \[[@B22]\]        67    M        right           not described    cystic
  7        Jennings \[[@B23]\]        32    F        left            14×11 cm         cystic
  8        Kato \[[@B24]\]            66    M        left            not described    solid
  9        Gutierrez \[[@B25]\]       30    F        both            18 cm            both
  10       Gramlich \[[@B26]\]        28    F        right           30×20×14 cm      both
  11       Alanen \[[@B27]\]          20    F        left            6×8 cm           both
  12       Ito \[[@B28]\]             43    F        both            16×16×7.7 cm     cystic
  13       Urabe \[[@B29]\]           39    F        left            1.2 cm           solid
  14       Drachenberg \[[@B30]\]     69    F        left            26×20×11.5 cm    both
  15       Wada \[[@B31]\]            62    M        left            6×6×4.5 cm       solid
  16       Chau \[[@B10]\]            53    M        right           20×14×10 cm      cystic
  17       Megremis \[[@B32]\]        56    F        both            7.5 cm           cystic
  18       Chung \[[@B33]\]           57    F        left            6×4×3.5 cm       solid
  19       Papastratis \[[@B34]\]     21    F        right           17×10 cm         cystic
  20       Cook \[[@B2]\]             46    F        right           6×4×5 cm         cystic
  21       Cook \[[@B2]\]             66    F        right           5×4×2 cm         cystic
  22       Cook \[[@B2]\]             63    F        left            11×16×24 cm      solid
  23       Brkic \[[@B35]\]           38    M        right           8×5 cm           solid
  24       Kim \[[@B36]\]             −     M        right           5 cm             both
  25       Yesim \[[@B8]\]            54    F        left            2.5×2.5×1.5 cm   cystic
  26       Yesim \[[@B8]\]            51    F        right           6×7×8 cm         cystic
  27       Ayadi-Kaddour \[[@B37]\]   21    F        left            11×5 cm          cystic
  28       Hernandez \[[@B5]\]        51    M        right           19×13 cm         solid
  29       Li \[[@B6]\]               33    F        both            not described    angiosarcoma
  30       Mori \[[@B7]\]             36    F        right           20×15×10 cm      cystic
  31       Current case               53    F        both            9×9×7.5 cm       both

###### 

Radiographie appearance of MHL \[[@B11],[@B12],[@B13]\]

  Imaging modality             Radiographie appearance
  ---------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ultrasound                   Anechoic, multilobular mass with thin septations.
                               
  Computed tomography          Appearance ranges from a multilocular cystic mass with solid septa to multiple small cysts in a solid mass. Contrast administration enhances the solid component without a change in the cystic portion.
                               
  Magnetic resonance imaging   The cystic component will show low signal intensity on Tl-weighted images and high intensity on T2-weighted images. Solid component will depict low intensity on Tl-weighted images due to fibrosis.
                               
  Angiography                  Cystic masses appear completely avascular due to displacement of major vessels. Predominantly solid lesions are hypovascular with small tumor vessels correlating to septa vascularization surrounding scattered cystic regions.
